Co-Authors
This is a "connection" page, showing publications co-authored by Motoi Suzuki and Tomimasa Sunagawa.
Connection Strength
1.483
-
High attack rate of SARS-CoV-2 infections during a bus tour in Japan. J Travel Med. 2021 12 29; 28(8).
Score: 0.247
-
Transmission Risk of SARS-CoV-2 Before and After Symptom Onset of the Infector. Jpn J Infect Dis. 2021 Aug 31.
Score: 0.241
-
Epidemiology of Coronavirus Disease 2019 in Japan: Descriptive Findings and Lessons Learned through Surveillance during the First Three Waves. JMA J. 2021 Jul 15; 4(3):198-206.
Score: 0.239
-
Clinical Characteristics and Risk Factors for Severe Outcomes of Novel Coronavirus Infection, January-March 2020, Japan. J Epidemiol. 2021 08 05; 31(8):487-494.
Score: 0.238
-
Possible contact transmission of SARS-CoV-2 in healthcare settings in Japan, 2020-2021. Infect Control Hosp Epidemiol. 2021 May 27; 1-12.
Score: 0.237
-
Excess All-Cause Deaths during Coronavirus Disease Pandemic, Japan, January-May 20201. Emerg Infect Dis. 2021 03; 27(3):789-795.
Score: 0.058
-
A Genome Epidemiological Study of SARS-CoV-2 Introduction into Japan. mSphere. 2020 11 11; 5(6).
Score: 0.057
-
Severe Acute Respiratory Syndrome Coronavirus 2 Infection among Returnees to Japan from Wuhan, China, 2020. Emerg Infect Dis. 2020 07; 26(7).
Score: 0.056
-
Clusters of Coronavirus Disease in Communities, Japan, January-April 2020. Emerg Infect Dis. 2020 09; 26(9).
Score: 0.055
-
Epidemiology of COVID-19 Outbreak in Japan, from January-March 2020. Jpn J Infect Dis. 2020 Sep 24; 73(5):391-393.
Score: 0.055